Literature DB >> 5061810

Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons.

T Hökfelt, K Fuxe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5061810     DOI: 10.1159/000122042

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  33 in total

1.  Editorial: Bromocriptine--a changing scene.

Authors: 
Journal:  Br Med J       Date:  1975-12-20

Review 2.  The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis.

Authors:  D D Rasmussen
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

Review 3.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

4.  Modulation of the actions of tyrosine by alpha 2-adrenoceptor blockade.

Authors:  S Al-Damluji; G Ross; R Touzel; D Perrett; A White; G M Besser
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

5.  Prolactin and human reproduction.

Authors:  G Tolis; H G Friesen
Journal:  Can Med Assoc J       Date:  1976-10-23       Impact factor: 8.262

6.  Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.

Authors:  H R Bürki; H Asper; W Ruch; P E Züger
Journal:  Psychopharmacology (Berl)       Date:  1978-05-31       Impact factor: 4.530

7.  Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.

Authors:  F Scapin; S Buonaccorsi; G Tronconi; G Pellicciotta; A E Pontiroli
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristics.

Authors:  A E Pontiroli; L Falsetti
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

9.  Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.

Authors:  H J Künzig; W Geiger; K D Schulz; K H Lose
Journal:  Arch Gynakol       Date:  1975

10.  Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

Authors:  G M Besser; L Parke; C R Edwards; I A Forsyth; A S McNeilly
Journal:  Br Med J       Date:  1972-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.